Linda Michele Delahanty, M.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Life Style | 54 | 2024 | 3886 | 3.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 67 | 2024 | 12075 | 2.810 |
Why?
|
| Weight Loss | 40 | 2023 | 2671 | 2.800 |
Why?
|
| Risk Reduction Behavior | 14 | 2018 | 1098 | 1.400 |
Why?
|
| Diabetes Mellitus | 21 | 2023 | 5816 | 1.250 |
Why?
|
| Obesity | 37 | 2023 | 12870 | 1.130 |
Why?
|
| Nutrition Therapy | 3 | 2024 | 101 | 1.120 |
Why?
|
| Dietetics | 5 | 2010 | 34 | 1.080 |
Why?
|
| Diet, Fat-Restricted | 8 | 2023 | 329 | 0.900 |
Why?
|
| Telephone | 3 | 2024 | 625 | 0.890 |
Why?
|
| Psychotherapy, Group | 3 | 2018 | 412 | 0.850 |
Why?
|
| Hypoglycemic Agents | 16 | 2020 | 3069 | 0.730 |
Why?
|
| Dietary Services | 5 | 2020 | 17 | 0.700 |
Why?
|
| Metformin | 13 | 2020 | 907 | 0.690 |
Why?
|
| Exercise | 24 | 2022 | 5788 | 0.640 |
Why?
|
| Diet, Reducing | 9 | 2015 | 485 | 0.590 |
Why?
|
| Diet Therapy | 1 | 2018 | 150 | 0.570 |
Why?
|
| Blood Glucose | 19 | 2024 | 6346 | 0.560 |
Why?
|
| Nutrition Assessment | 3 | 2017 | 726 | 0.450 |
Why?
|
| Health Behavior | 10 | 2020 | 2617 | 0.440 |
Why?
|
| Body Mass Index | 23 | 2018 | 12876 | 0.430 |
Why?
|
| Diet | 15 | 2024 | 8005 | 0.420 |
Why?
|
| Insulin | 11 | 2022 | 6578 | 0.420 |
Why?
|
| Nutrition Policy | 3 | 2015 | 470 | 0.410 |
Why?
|
| Overweight | 11 | 2022 | 2411 | 0.390 |
Why?
|
| Blood Glucose Self-Monitoring | 4 | 2022 | 457 | 0.370 |
Why?
|
| Primary Health Care | 5 | 2020 | 4652 | 0.350 |
Why?
|
| Diabetes Complications | 4 | 2008 | 1317 | 0.340 |
Why?
|
| Weight Gain | 4 | 2015 | 2346 | 0.320 |
Why?
|
| Middle Aged | 66 | 2024 | 219568 | 0.300 |
Why?
|
| Motivation | 8 | 2019 | 1996 | 0.300 |
Why?
|
| Metabolic Diseases | 1 | 2014 | 682 | 0.290 |
Why?
|
| Energy Intake | 9 | 2023 | 2127 | 0.290 |
Why?
|
| Primary Prevention | 4 | 2013 | 1185 | 0.290 |
Why?
|
| Cardiovascular Diseases | 9 | 2024 | 15399 | 0.290 |
Why?
|
| Patient Compliance | 8 | 2017 | 2685 | 0.280 |
Why?
|
| Professional Role | 1 | 2010 | 309 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2008 | 3432 | 0.280 |
Why?
|
| Humans | 107 | 2024 | 758406 | 0.270 |
Why?
|
| Body Weight | 8 | 2014 | 4603 | 0.270 |
Why?
|
| Female | 79 | 2024 | 390323 | 0.260 |
Why?
|
| Male | 76 | 2024 | 358747 | 0.260 |
Why?
|
| Dietary Fats | 9 | 2020 | 1991 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2020 | 15773 | 0.260 |
Why?
|
| Triglycerides | 3 | 2024 | 2451 | 0.250 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2017 | 128 | 0.240 |
Why?
|
| Hypercholesterolemia | 2 | 2002 | 1138 | 0.240 |
Why?
|
| Health Promotion | 5 | 2014 | 2204 | 0.220 |
Why?
|
| Food Supply | 2 | 2020 | 543 | 0.220 |
Why?
|
| Prediabetic State | 3 | 2019 | 547 | 0.210 |
Why?
|
| Dietary Carbohydrates | 5 | 2020 | 890 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2022 | 10146 | 0.200 |
Why?
|
| Feeding Behavior | 7 | 2023 | 3184 | 0.200 |
Why?
|
| Quality of Life | 6 | 2022 | 13285 | 0.200 |
Why?
|
| Adult | 40 | 2024 | 219935 | 0.200 |
Why?
|
| Postprandial Period | 2 | 2021 | 314 | 0.200 |
Why?
|
| Evidence-Based Medicine | 3 | 2010 | 3671 | 0.180 |
Why?
|
| Motor Activity | 6 | 2015 | 2685 | 0.180 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2017 | 597 | 0.180 |
Why?
|
| Genetic Counseling | 3 | 2012 | 624 | 0.170 |
Why?
|
| Self Care | 4 | 2013 | 794 | 0.170 |
Why?
|
| Aged | 34 | 2024 | 168218 | 0.170 |
Why?
|
| Dietary Fiber | 3 | 2020 | 759 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2007 | 362 | 0.160 |
Why?
|
| Patient Satisfaction | 2 | 2002 | 3446 | 0.160 |
Why?
|
| Stress, Psychological | 4 | 2014 | 4455 | 0.150 |
Why?
|
| Eating | 5 | 2022 | 1536 | 0.150 |
Why?
|
| Caloric Restriction | 3 | 2018 | 296 | 0.140 |
Why?
|
| Hypoglycemia | 3 | 2017 | 881 | 0.140 |
Why?
|
| PPAR gamma | 2 | 2011 | 482 | 0.140 |
Why?
|
| Menu Planning | 1 | 1996 | 28 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 4 | 2018 | 5484 | 0.140 |
Why?
|
| Qualitative Research | 2 | 2024 | 2976 | 0.130 |
Why?
|
| Foods, Specialized | 1 | 2015 | 4 | 0.130 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 86 | 0.130 |
Why?
|
| Patient Education as Topic | 5 | 2012 | 2307 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2021 | 840 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2019 | 570 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2018 | 387 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 3175 | 0.120 |
Why?
|
| Communication Barriers | 1 | 2018 | 413 | 0.120 |
Why?
|
| Personal Autonomy | 1 | 2016 | 302 | 0.120 |
Why?
|
| Nutritional Sciences | 3 | 2007 | 143 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 21017 | 0.120 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2014 | 69 | 0.110 |
Why?
|
| Treatment Outcome | 13 | 2018 | 64378 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2020 | 39059 | 0.110 |
Why?
|
| Dysthymic Disorder | 1 | 2013 | 75 | 0.110 |
Why?
|
| Physical Fitness | 2 | 2017 | 732 | 0.110 |
Why?
|
| Genotype | 6 | 2013 | 12945 | 0.110 |
Why?
|
| Program Evaluation | 2 | 2019 | 2492 | 0.110 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2014 | 193 | 0.110 |
Why?
|
| Fruit | 3 | 2014 | 1160 | 0.100 |
Why?
|
| Medical Futility | 1 | 2014 | 133 | 0.100 |
Why?
|
| Vegetables | 3 | 2014 | 1195 | 0.100 |
Why?
|
| New York | 1 | 2014 | 874 | 0.100 |
Why?
|
| Patient Care Team | 3 | 2016 | 2504 | 0.100 |
Why?
|
| Lysophospholipase | 1 | 2011 | 65 | 0.100 |
Why?
|
| Risk Factors | 13 | 2021 | 73809 | 0.100 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 927 | 0.100 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 350 | 0.100 |
Why?
|
| Proinsulin | 1 | 2011 | 135 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 324 | 0.090 |
Why?
|
| Hyperglycemia | 2 | 2017 | 1368 | 0.090 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6234 | 0.090 |
Why?
|
| Chromans | 2 | 2008 | 117 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 1998 | 973 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2014 | 921 | 0.090 |
Why?
|
| Behavior | 1 | 1993 | 540 | 0.090 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 158 | 0.090 |
Why?
|
| Medication Adherence | 3 | 2018 | 2155 | 0.090 |
Why?
|
| Depression | 5 | 2014 | 8057 | 0.090 |
Why?
|
| Physical Exertion | 3 | 2014 | 662 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 263 | 0.090 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 468 | 0.090 |
Why?
|
| Counseling | 3 | 2013 | 1541 | 0.080 |
Why?
|
| Alleles | 4 | 2014 | 6895 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 977 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 1066 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2002 | 3387 | 0.080 |
Why?
|
| Anthropometry | 1 | 2013 | 1347 | 0.080 |
Why?
|
| Thiazolidinediones | 2 | 2008 | 460 | 0.070 |
Why?
|
| United States | 11 | 2019 | 72136 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2022 | 14490 | 0.070 |
Why?
|
| Genetic Loci | 2 | 2017 | 2612 | 0.070 |
Why?
|
| Sleep | 1 | 2022 | 4744 | 0.070 |
Why?
|
| Cholesterol, LDL | 3 | 2024 | 2374 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 896 | 0.070 |
Why?
|
| Body Composition | 2 | 2013 | 2416 | 0.070 |
Why?
|
| Insulin Resistance | 4 | 2013 | 3941 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2015 | 2026 | 0.070 |
Why?
|
| Health Literacy | 1 | 2012 | 441 | 0.070 |
Why?
|
| Genetic Testing | 4 | 2012 | 3530 | 0.070 |
Why?
|
| Adolescent | 10 | 2021 | 87892 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2019 | 17768 | 0.060 |
Why?
|
| Proteins | 2 | 2011 | 6026 | 0.060 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 1241 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2018 | 3991 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2012 | 867 | 0.060 |
Why?
|
| Research | 1 | 1993 | 1976 | 0.060 |
Why?
|
| Health Education | 1 | 2011 | 1049 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 3 | 2007 | 7378 | 0.060 |
Why?
|
| Incidence | 4 | 2015 | 21272 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1895 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9273 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2020 | 1172 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 2048 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2011 | 7843 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1734 | 0.050 |
Why?
|
| Depressive Disorder, Major | 2 | 2013 | 4745 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2008 | 869 | 0.050 |
Why?
|
| Telemedicine | 1 | 2019 | 3018 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 1984 | 259 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2022 | 54137 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2006 | 632 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2011 | 3992 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2013 | 6354 | 0.050 |
Why?
|
| Dietary Proteins | 2 | 2020 | 949 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 2012 | 1808 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10748 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4284 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2006 | 970 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4938 | 0.040 |
Why?
|
| Genetic Association Studies | 3 | 2015 | 2717 | 0.040 |
Why?
|
| Bulimia | 1 | 2002 | 400 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 6362 | 0.040 |
Why?
|
| Glycemic Index | 1 | 2021 | 393 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2006 | 1398 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 300 | 0.040 |
Why?
|
| C-Peptide | 1 | 2020 | 433 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 8530 | 0.040 |
Why?
|
| Child | 6 | 2018 | 79818 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2872 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2002 | 575 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3915 | 0.040 |
Why?
|
| Massachusetts | 2 | 2020 | 8823 | 0.040 |
Why?
|
| Patient Selection | 1 | 2010 | 4244 | 0.040 |
Why?
|
| Food | 1 | 2002 | 771 | 0.040 |
Why?
|
| Psychometrics | 1 | 2006 | 3052 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 414 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2850 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 2629 | 0.030 |
Why?
|
| Psychological Theory | 1 | 2016 | 175 | 0.030 |
Why?
|
| Hand Strength | 1 | 2018 | 452 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2008 | 3727 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6157 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 1386 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 58808 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2017 | 412 | 0.030 |
Why?
|
| Menopause | 1 | 2022 | 1639 | 0.030 |
Why?
|
| Metabolic Equivalent | 1 | 2014 | 14 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 963 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2018 | 518 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2014 | 3612 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 12094 | 0.030 |
Why?
|
| Inservice Training | 1 | 2016 | 375 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2007 | 58683 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2019 | 919 | 0.030 |
Why?
|
| Television | 1 | 2015 | 409 | 0.030 |
Why?
|
| Risk | 2 | 2015 | 9599 | 0.030 |
Why?
|
| Sex Factors | 1 | 2006 | 10504 | 0.030 |
Why?
|
| Glucose | 2 | 2022 | 4336 | 0.020 |
Why?
|
| Social Marketing | 1 | 2011 | 52 | 0.020 |
Why?
|
| Diet Records | 1 | 1993 | 427 | 0.020 |
Why?
|
| Placebos | 2 | 2007 | 1661 | 0.020 |
Why?
|
| Child Behavior | 1 | 2017 | 847 | 0.020 |
Why?
|
| Anxiety | 1 | 2006 | 4539 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2017 | 41256 | 0.020 |
Why?
|
| Time Factors | 4 | 2015 | 39872 | 0.020 |
Why?
|
| Lipids | 1 | 2001 | 3326 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 171 | 0.020 |
Why?
|
| Group Processes | 1 | 2011 | 226 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2013 | 12262 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7818 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1501 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 1996 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 1184 | 0.020 |
Why?
|
| Dairy Products | 1 | 2012 | 491 | 0.020 |
Why?
|
| Weight Perception | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 25956 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 809 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 838 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1240 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2012 | 1161 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2012 | 881 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2797 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2388 | 0.020 |
Why?
|
| Comorbidity | 2 | 2014 | 10495 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2012 | 23884 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2121 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1415 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 456 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 1993 | 1433 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 425 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2751 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 1716 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2100 | 0.020 |
Why?
|
| Citrus | 1 | 1985 | 44 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 1599 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 298 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2020 | 6548 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 603 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1894 | 0.010 |
Why?
|
| Speech Therapy | 1 | 1984 | 57 | 0.010 |
Why?
|
| Geriatric Psychiatry | 1 | 1984 | 71 | 0.010 |
Why?
|
| Nursing Care | 1 | 1984 | 65 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2432 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20055 | 0.010 |
Why?
|
| Insulin Infusion Systems | 1 | 1985 | 217 | 0.010 |
Why?
|
| Occupational Therapy | 1 | 1984 | 139 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8426 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9267 | 0.010 |
Why?
|
| Social Support | 1 | 2012 | 2155 | 0.010 |
Why?
|
| Finland | 1 | 2004 | 603 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 1628 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3759 | 0.010 |
Why?
|
| Milk | 1 | 1985 | 443 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 1996 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1993 | 3561 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1705 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 802 | 0.010 |
Why?
|
| Sweden | 1 | 2004 | 1376 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 1984 | 536 | 0.010 |
Why?
|
| Critical Care | 1 | 1993 | 2692 | 0.010 |
Why?
|
| Indians, North American | 1 | 2004 | 350 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12440 | 0.010 |
Why?
|
| Educational Status | 1 | 2008 | 2513 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13276 | 0.010 |
Why?
|
| Beverages | 1 | 1985 | 819 | 0.010 |
Why?
|
| Income | 1 | 2008 | 1872 | 0.010 |
Why?
|
| Linear Models | 1 | 2009 | 5862 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29557 | 0.010 |
Why?
|
| China | 1 | 2004 | 2333 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12604 | 0.010 |
Why?
|
| Forecasting | 1 | 2006 | 2923 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2006 | 2868 | 0.010 |
Why?
|
| Hemoglobin A | 1 | 1993 | 84 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 29742 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15225 | 0.010 |
Why?
|
| Health Status | 1 | 2006 | 4071 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 18358 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 7985 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1987 | 3299 | 0.000 |
Why?
|
| Animals | 1 | 1985 | 167768 | 0.000 |
Why?
|